Phase 3 RDT Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study of ALK-001 on the Progression of Stargardt Disease
Stargardt Disease
Alkeus Pharmaceuticals, Inc.230 enrolled1 locationNCT07419334
Recruiting
Phase 2Phase 3
A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease
Stargardt Disease
Ocugen51 enrolled14 locationsNCT05956626